Bleomycin (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Bleomycin drug offered from Teva Parenteral Medicines, Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | Bleomycin |
SUBSTANCE NAME: | BLEOMYCIN SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-06-30 |
END MARKETING DATE: | 0000-00-00 |
Bleomycin HUMAN PRESCRIPTION DRUG Details:
Item Description | Bleomycin from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15([USP’U]/1) |
START MARKETING DATE: | 2000-06-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0703-3154_d7637555-32ed-4800-b6ae-ee58bd5a4702 |
PRODUCT NDC: | 0703-3154 |
APPLICATION NUMBER: | ANDA065033 |
Other BLEOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers: